Hybrid Event
- This event has passed.
Characterizing Immune-12, a complex marine-derived nutraceutical that exhibits anti-cancer activity in vitro and in vivo with minimal toxicity
September 8, 2025 @ 11:30 am - 12:30 pm
Hybrid Event
Presented by:
Andrew Satterlee, Ph.D.
Screening Live Cancer Explants Program, Eshelman Innovation
UNC Eshelman School of Pharmacy
Division of Pharmacoengineering and Molecular Pharmaceutics
Register Here
Hosted by: UNC Metabolomics and Proteomics (MAP) Core
Sponsored by: UNC Lineberger Comprehensive Cancer Center (LCCC)